Yaupon names Steve Tullman chairman and CEO
This article was originally published in Scrip
Executive Summary
Yaupon Therapeutics, a privately held speciality pharma company developing small-molecule pharmaceuticals licensed from academic institutions, has appointed Steve Tullman chairman and CEO. Mr Tullman was previously co-founder and president of Ception Therapeutics, which was acquired by Cephalon in 2010. He currently serves as chairman of Vicept Therapeutics.